US pharma major Eli Lilly (NYSE: LLY) has partnered with chipmaker NVIDIA (Nasdaq: NVDA) to develop an AI supercomputer for pharmaceutical research, a collaboration that GlobalData says could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback